Frontlight ResearchEarly access
Trial site
IRCCS Ospedale Casa Sollievo della Sofferenza
- 8running trials
- 4closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Gastric and oesophageal cancer2 trials
- Multiple myeloma2 trials
- Ulcerative colitis2 trials
- Bladder cancer1 trial
- Crohn's disease1 trial
- Diffuse large B-cell lymphoma1 trial
- Heart failure1 trial
- Liver and biliary tract cancer1 trial
- Lung cancer1 trial
- Metastatic breast cancer1 trial
- Phase
- Phase 36 trials
- Phase 22 trials
- Status
- Active, not recruiting5 trials
- Completed4 trials
- Recruiting3 trials
- Lead sponsor
- Hoffmann-La Roche2 trials
- BeiGene1 trial
- CytoSorbents, Inc1 trial
- Daiichi Sankyo1 trial
- Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1 trial
- and 6 more
Running trials
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
A "Physician & Patient-powered" Cohort Registry (MY MYELOMA)
Active, not recruiting
Active, not recruiting
Atezolizumab Versus Atezolizumab Plus Bevacizumab as First Line in NSCLC Patients (BEAT)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Gastric and oesophageal cancer1 recruiting
- Heart failure1 recruiting
- Multiple myeloma1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026